Q2 2017 13F Holders as of 30 Jun 2017
-
Type / Class
-
Debt / NOTE 2.750% 7/1
-
Market price (% of par)
-
104.84%
-
Total 13F principal
-
$390,045,000
-
Principal change
-
+$390,045,000
-
Total reported market value
-
$409,175,731
-
Number of holders
-
42
-
Value change
-
+$409,175,731
-
Number of buys
-
42
Institutional Holders of MEDICINES CO - NOTE 2.750% 7/1 as of Q2 2017
As of 30 Jun 2017,
MEDICINES CO - NOTE 2.750% 7/1 was held by
42 institutional
bondholders
reporting positions in Form 13F filings.
These institutions reported holding
$390,045,000
in principal (par value) of the bond.
The largest 10 bondholders included
CITADEL ADVISORS LLC, LINDEN ADVISORS LP, Partner Fund Management, L.P., WOLVERINE ASSET MANAGEMENT LLC, ZAZOVE ASSOCIATES LLC, CAPSTONE INVESTMENT ADVISORS, LLC, LAZARD ASSET MANAGEMENT LLC, D. E. Shaw & Co., Inc., DEUTSCHE BANK AG\, and Calamos Advisors LLC.
This page lists
42
institutional bondholders reporting positions
for the Q2 2017 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price (% of par)
|
Principal |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.